NCT01049724

Brief Summary

The purpose of this study is to measure tear lacritin and heparanase levels before and following surgery using a minimal risk procedure to collect tears from patients undergoing PRK or LASIK.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
196

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 14, 2010

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

February 7, 2018

Status Verified

February 1, 2018

Enrollment Period

7.8 years

First QC Date

January 13, 2010

Last Update Submit

February 6, 2018

Conditions

Keywords

Myopiarefractive surgeryLASIKPRKLacritinHeparanase

Outcome Measures

Primary Outcomes (1)

  • The primary outcome measure is tear lacritin levels pre- and post-surgery.

    pre and standard visits up to 6 months post-surgery

Secondary Outcomes (1)

  • The secondary outcome is tear heparanase levels pre- and post-surgery

    pre- and at standard visits up to 6 months post-surgery

Study Arms (2)

PRK

Those patients undergoing photorefractive keratectomy

Other: Tear collection

LASIK

Those undergoing Laser-assisted insitu keratomileusis

Other: Tear collection

Interventions

Tear collection

LASIKPRK

Eligibility Criteria

Age21 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Active duty military aged 21 to 55 with myopia up to -10.00 diopters eligible for care at Walter Reed Army Medical Center.

You may qualify if:

  • Active duty US Army Soldiers eligible for care at FBCH
  • Undergoing PRK or LASIK
  • Male or female, of any race, and at least 21 years old and not older than 55 years old at the time of the tear collection. The lower age limit of 21 years is intended to ensure documentation of refractive stability.
  • Appropriately aged individuals who report that their eyes are "normal" and who have no active eye illness as determined by the principal investigator or sub-investigator.
  • Ability and willingness to understand and provide informed consent to participate in this study.
  • Up to -10.00 diopters of myopia.
  • Subject must expect to be located in the greater Washington DC area for a 12 month period post-operatively.
  • Consent of the subject's command (active duty) to participate in the study.
  • Access to transportation to meet follow-up requirements.

You may not qualify if:

  • Any reason to be excluded for PRK or LASIK
  • Female subjects who are pregnant, breast-feeding or intend to become pregnant during the study. Female subjects will be given a urine pregnancy test prior to participating in the study to rule out pregnancy. \[Pregnancy and breastfeeding are contraindications to refractive surgery in general, including PRK, whether participating in this study or not\]
  • Patients with known sensitivity or inappropriate responsiveness to any of the medications used in the post-operative course.
  • Any physical or mental impairment that would preclude participation in any of the examinations.
  • Anterior basement membrane dystrophy
  • History of recurrent epithelial erosion
  • Significant dry eye (symptomatic with Schirmer \<5mm at 5 minutes)
  • Other corneal epithelial disorder or healing abnormality
  • Individuals with any infectious or inflammatory ocular conditions (e.g. have "pink eye" or uveitis).
  • Individuals diagnosed with dry eye or other ocular surface condition, including but not restricted to neurotropic keratitis, anterior basement membrane dystrophy, and recurrent corneal erosions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fort Belvoir Community Hospital

Fort Belvoir, Virginia, 22060, United States

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Kraig S. Bower, MD

    The Wilmer Eye Institute, Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir

Study Record Dates

First Submitted

January 13, 2010

First Posted

January 14, 2010

Study Start

January 1, 2010

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

February 7, 2018

Record last verified: 2018-02

Locations